MARY WANG: Open Payments
NPI 1427358076 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,049 in 35 payments from 8 companies in 2025. Trend: 2023 $636 · 2024 $2,456 · 2025 $4,049
Consulting: $2,688Food & beverage: $1,062Travel & lodging: $299
| Company | Payments | Amount |
|---|---|---|
| COLOPLAST CORP | 8 | $3,133 |
| Medtronic, Inc. | 4 | $374 |
| Sumitomo Pharma America, Inc. | 10 | $200 |
| DENTSPLY IH AB | 8 | $142 |
| Astellas Pharma US Inc | 1 | $118 |
| UROGEN PHARMA, INC. | 2 | $46 |
| 180 Medical, Inc. | 1 | $21 |
| Ambu Inc. | 1 | $16 |
Products named: Luja Coude, SpeediCath, INTERSTIM, GEMTESA, LOFRIC, Veozah, NURO, ZUSDURI.
Industry payments across PA — which companies pay providers there.
